Techniques such as direct immunofluorescence (DIF) for distinguishing certain skin disorders are not always available in many countries and smaller centres, limiting their diagnostic utility. It has been postulated that periodic acid-Schiff (PAS) staining of basement membrane can correspond to DIF staining patterns seen in epidermolysis bullosa acquisita (EBA) and bullous pemphigoid (BP).
Techniques such as direct immunofluorescence (DIF) for distinguishing certain skin disorders are not always available in many countries and smaller centres, limiting their diagnostic utility. It has been postulated that periodic acid-Schiff (PAS) staining of basement membrane can correspond to DIF staining patterns seen in epidermolysis bullosa acquisita (EBA) and bullous pemphigoid (BP).
Formation of bullae in BP is mediated through autoantibodies directed against BP antigen 180 (BP180) and BP antigen 230 (BP230), both of which are components of hemidesmosomes that connect basal keratinocytes to the basement membrane zone. 1 Bullae formed in EBA are mediated through autoantibodies directed against type VII collagen, the major component of anchoring fibrils in the dermal-epidermal junction that connect the base of the basement membrane to the dermis. 2 Direct immunofluorescence performed on a specimen of either BP or EBA will show linear deposition of immunoglobulin G (IgG) and/or complement C3 along the basement membrane zone. Examination of a specimen with an artefactual subepidermal split at the level of the lamina lucida created by incubation in hypertonic saline (salt-split skin technique) localises the immune deposits to the epidermal side (roof) in BP and the dermal side (floor) in EBA. 3 PAS staining highlights the normal basement membrane. In BP, given that the autoantibodies are inducing a cleft in the region BP180 and BP230 on the more superficial side of the basement membrane, we would expect the bulla formed to localise the majority of the basement membrane complex to the dermal side (floor) of the specimen. Conversely, in EBA, we would expect to see the basement membrane localise to the epidermal side (roof) of the specimen, given that the It has also been suggested that the type of inflammatory infiltrate or the absence or presence of fraying of basal keratinocytes may differentiate these 2 conditions. A predominantly eosinophilic infiltrate has been associated with BP, while a predominantly neutrophilic infiltrate has been associated with EBA. The damage to basal keratinocytes induced by disruption of the intracellular BP230 antigen and of the intracellular portion of the BP180 antigen has led to the postulation that fraying of basal keratinocytes is more commonly seen with bullous pemphigoid, in which the keratinocytes are torn from the basement membrane when the bulla is formed. In comparison, a lack of fraying is expected with EBA, in which the intact basal keratinocytes would still be attached to the basement membrane on the epidermal side of the split.
We hypothesised that PAS staining of the basement membrane on the blister roof, presence of a predominantly neutrophilic infiltrate, lack of eosinophilic infiltrate, and absence of keratinocyte fraying may be used to help distinguish EBA from BP without the use of DIF.
Materials and Methods
Patients with the phrase 'epidermolysis bullosa acquisita' in the final diagnosis on pathology report from 2003 to 2016 were identified using the Vancouver Coastal Health Authority laboratory database. This search generated 257 reports. Cases were excluded if they did not have a final positive diagnosis of EBA, if they were not confirmed by DIF, if the patient did not have a routine specimen in addition to the specimen submitted for DIF, if there was no evidence of a subepidermal blister on the routine specimen, or if they were referred from outside of our health region. Using these criteria, we identified 13 positive cases of EBA over that time.
Using the same exclusion criteria, the database was then searched for patients with the phrase 'bullous pemphigoid' in the final diagnosis on pathology report over the preceding 18 months, revealing 204 reports for review. The most recent 19 positive cases of BP, confirmed by DIF, with a subepidermal split on the routinely processed sections were identified.
The gold standard for diagnosis of EBA vs BP was taken to be identification of immune deposits on the dermal side (floor) for EBA or the epidermal side (roof) for BP of the salt-split DIF specimen.
All histologic sections for the 32 positive diagnoses (13 for EBA, 19 for BP) were retrieved for examination. PAS staining with diastase was performed for any cases in which there was not already an existing PAS stain available. One investigator was blinded to the original diagnoses and reviewed the slides, which were then categorised according to PAS basement membrane staining (roof or floor) (Figure 1) , type of inflammatory infiltrate (predominantly neutrophils, eosinophils, or pauci-inflammatory) within a radius of 1 dermal papilla from the site of formation of the subepidermal split, and absence or presence of basal keratinocyte fraying (Figure 2) .
Results
We performed Bayesian analysis of the diagnostic tests with the following results shown in Tables 1 through 4. One slide was excluded from analysis of basement membrane zone staining by PAS as the basement membrane zone was identified unattached, in the centre of the subepidermal split (on neither roof nor floor).
Sensitivity (Sn) and specificity (Sp) for each test were as follows: PAS staining of roof (Sn 25%, Sp 95%), neutrophilic infiltrate (Sn 54%, Sp 74%), lack of eosinophilic infiltrate (Sn 92%, Sp 68%), and absence of keratinocyte fraying (Sn 62%, Sp 58%).
Discussion
None of the features we examined in the routinely processed biopsy, including PAS staining of the basement membrane zone, the type of inflammatory infiltrate, and the absence or 
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presence of basal keratinocyte fraying, demonstrated sufficient sensitivity and specificity to reliably distinguish EBA from BP. The most sensitive test for EBA was a lack of eosinophilic infiltrate, with a sensitivity of 92%, indicating that eosinophils are rarely the predominant cell type in EBA; however, this lack of eosinophils had only a 68% specificity. The most specific test was PAS staining of the basement membrane localising to the roof of the subepidermal split for EBA, with a specificity of 95%, suggesting that localisation of the basement membrane to the blister roof rarely occurs in BP; however, the very low sensitivity of only 25% indicates its ability to identify only a small proportion of the cases of EBA.
Given the good understanding in both EBA and BP of the level of the basement membrane complex at which autoantibody-induced damage occurs, we expected both our sensitivities and our specificities to be higher. There are potential explanations for the appearance of the PAS-stained basement membrane in the base of many cases of EBA: it is possible that PAS stains not only the lamina densa but also type VII collagen and other components that are on the dermal side of the basement membrane complex, and these deeper stainable components persist on the dermal side after pathologic splitting in the region of type VII collagen; alternatively, despite antibody deposition at the level of type VII collagen, the resulting pathologic split may still occur more superficially at the lamina lucida because of factors related to structural weakness or preferential localisation of destructive mediators of inflammation. Similarly, the fraying of basal keratinocytes seen in many cases of EBA may occur as a result of spread of inflammatory damage upward from the initial site of type VII collagen.
Weaknesses of this study include the small sample selection, the inability to apply population-based statistics such as positive and negative predictive value because of the relative rarity of EBA, and the possibility of an observer expectancy effect arising from the parameters initially assessed on any given case subsequently affecting judgment of the other parameters on the same case. Another potential source for error is our use of salt-split DIF results as the gold standard for distinction of BP and EBA. Ultimately, these 2 disorders are defined by their antigenic targets, and it may be that salt-split DIF results would not have corresponded perfectly to diagnoses defined by a combination of histology, DIF, and Western immunoblotting for definitive confirmation of the target antigens.
Although our goal was to provide a reliable, cost-effective, and simple way to distinguish between EBA and BP on a routinely processed biopsy, the results of our tests indicate that, at this time, direct immunofluorescence (or indirect immunofluorescence) on salt-split skin remains the standard for distinction between EBA and BP. However, 2 findings on routine histology, if present, should prompt a high level of suspicion for EBA: the presence of the stainable basement membrane zone along the roof of the pathologic blister and a lack of eosinophil-predominant inflammation at the site of blister formation. 
